Apyx Medical Corp 8-KCurrent Reports (8-K / ad hoc)

Market for Equity / Stockholders

Item 5.07. Submission of Matters to a Vote of Security Holders. On August 6, 2026, the following proposals were submitted to the stockholders of the Company at its Annual Meeting: (1) the election of five (5) directors; (2) the ratification of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026; (3) the approval of a non-binding advisory resolution supporting the compensation of the Company’s named executive officers; and (4) the approval of the Company’s 2026 Share Incentive Plan. The proposals are described in more detail in the Proxy Statement. The following are the final voting results for each proposal: Proposal 1: The Company’s stockholders elected each of the following five (5) directors to serve on the Board of Directors of the Company until the 2027 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, by the following vote: Name Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained Broker Non-Votes Stavros G. Vizirgianakis 18,051,294 4,083,005 84,359 7,677,267 Charles D. Goodwin 21,338,164 788,416 92,078 7,677,267 Lawrence J. Waldman 21,332,747 718,782 167,129 7,677,267 Minnie Baylor-Henry 15,400,914 6,650,608 167,136 7,677,267 Wendy Levine 15,395,258 6,656,271 167,129 7,677,267 Proposal 2: The Company’s stockholders ratified the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026, by the following vote: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained Broker Non-Votes 29,814,618 31,610 49,697 - Field: Page; Sequence: 2 Field: /Page Proposal 3: The Company’s stockholders approved a non-binding advisory resolution supporting the compensation of the Company’s named executive officers, by the following vote: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained Broker Non-Votes 21,458,554 669,298 90,806 7,677,267 Proposal 4: The Company’s stockholders approved the Company’s 2026 Share Incentive Plan, by the following vote: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained Broker Non-Votes 16,186,776 2,755,882 3,276,000 7,677,267